EPAS1 and atherosclerosis: Adipocyte HIF-2α deficiency exacerbated Western-diet-induced atherosclerosis by increasing adipose ceramide levels, which could blunt hepatocyte cholesterol elimination and thermogenesis.92 This research highlights adipocyte HIF-2α as a putative pharmacological target for combating atherosclerosis.